REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 167 filers reported holding REGENXBIO INC in Q3 2019. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $262,000 | -23.8% | 5,095 | -15.1% | 0.00% | 0.0% |
Q1 2019 | $344,000 | -38.5% | 5,999 | -55.0% | 0.00% | -50.0% |
Q4 2018 | $559,000 | -39.8% | 13,331 | +8.5% | 0.00% | 0.0% |
Q3 2018 | $928,000 | +218.9% | 12,286 | +203.3% | 0.00% | +100.0% |
Q2 2018 | $291,000 | – | 4,051 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |